Complement-mediated inflammation and injury in brain dead organ donors
Related Experiment Video
Updated: Mar 10, 2026

Study of Experimental Organ Donation Models for Lung Transplantation
Published on: March 15, 2024
Felix Poppelaars1, Marc A Seelen1
1Department of Internal Medicine, Division of Nephrology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.
Insights
The complement system contributes to organ damage in brain-dead (BD) donors. Inhibiting complement reduces inflammation and improves graft survival, offering new therapeutic opportunities for transplantation.
Area of Science:
- Immunology
- Transplantation Medicine
- Nephrology
Background:
- The complement system's role in renal ischemia-reperfusion injury and acute rejection is known.
- Its contribution to donor tissue damage in brain-dead (BD) organ donors is less understood.
- BD is associated with systemic and local complement activation, inflammation, and graft injury.
Purpose of the Study:
- To investigate the role of the complement system in donor organ damage during brain death.
- To explore complement activation as a predictive marker for post-transplant graft function.
- To evaluate complement inhibition as a therapeutic strategy to improve organ quality for transplantation.
Main Methods:
- Review of existing literature on complement system activation in BD organ donors.
- Analysis of experimental models demonstrating the effects of complement inhibition.
- Discussion of potential clinical applications of complement-targeted therapies.
Main Results:
- Complement is activated systemically and locally in BD organ donors, mediating inflammation and graft injury.
- Complement activation levels can predict graft function post-transplantation.
- Inhibition of the complement cascade in experimental BD models reduces inflammation and injury, improving graft outcomes.
Conclusions:
- The complement system plays a significant role in donor organ damage in the context of brain death.
- Targeting the complement cascade offers a promising therapeutic avenue to enhance organ quality and transplant success.
- Further research is needed to fully elucidate the mechanisms of complement activation in BD organ donors.
Abstract:
The importance of the complement system in renal ischemia-reperfusion injury and acute rejection is widely recognized, however its contribution to the pathogenesis of tissue damage in the donor remains underexposed. Brain-dead (BD) organ donors are still the primary source of organs for transplantation. Brain death is characterized by hemodynamic changes, hormonal dysregulation, and immunological activation. Recently, the complement system has been shown to be involved. In BD organ donors, complement is activated systemically and locally and is an important mediator of inflammation and graft injury. Furthermore, complement activation can be used as a clinical marker for the prediction of graft function after transplantation. Experimental models of BD have shown that inhibition of the complement cascade is a successful method to reduce inflammation and injury of donor grafts, thereby improving graft function and survival after transplantation. Consequently, complement-targeted therapeutics in BD organ donors form a new opportunity to improve organ quality for transplantation. Future studies should further elucidate the mechanism responsible for complement activation in BD organ donors.
Related Concept Videos
Complement System
Cell-mediated Immune Responses
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Inflammation

